TickerGuard
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Warby Parker Inc (WRBY)

Healthcare Medical Instruments & Supplies
26.70 $
+2.6% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns Warby Parker Inc (WRBY)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 87.3% of the shares are freely tradable; institutional investors hold 102.3%.

Ownership Structure

Institutional ownership
102.3%
Insiders
5.8%
Float
87.3%
Short % of float
20.8%
Shares Outstanding
107Mio.

Largest Shareholders

Institutions

Institutions WRBY
Name Stake (%) Shares Change (%) Date
FMR Inc 12.65 15,526,372 +1.0 03/31/2026
JPMorgan Chase & Co 8.22 10,088,109 +4.2 03/31/2026
BlackRock Inc 5.92 7,259,063 -9.0 03/31/2026
Durable Capital Partners LP 5.21 6,396,513 -12.5 03/31/2026
Vanguard Portfolio Management, LLC 4.34 5,331,553 +0.0 03/31/2026
Vanguard Capital Management, LLC 3.59 4,403,508 +0.0 03/31/2026

Funds

Funds WRBY
Name Stake (%) Shares Change (%) Date
iShares Core S&P Small-Cap ETF 5.00 6,140,495 +0.0 07/28/2026
Fidelity Blue Chip Growth Composite 3.78 4,643,456 +0.0 03/31/2026
Fidelity Blue Chip Growth 3.75 4,605,777 +0.0 06/30/2026
Vanguard Morn Total Stk Mkt Idx Investor 2.63 3,226,847 -0.2 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
6. Jul 2026 Gilboa David Abraham Co-Chief Executive Officer Sell 54,347 29.84 1,621,714
6. Jul 2026 Gilboa David Abraham Co-Chief Executive Officer Other 54,347 0.00
6. Jul 2026 Blumenthal Neil Harris Co-Chief Executive Officer Sell 9,200 29.99 275,908
6. Jul 2026 Blumenthal Neil Harris Co-Chief Executive Officer Other 9,200 0.00
20. Apr 2026 Neil Harris Blumenthal CEO Sell 22,442 25.09 563,070
17. Apr 2026 Neil Harris Blumenthal CEO Sell 75,213 24.56 1,847,231

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?